FINWIRES · TerminalLIVE
FINWIRES

テネット・ヘルスケアの株価は、第1四半期の調整後利益と売上高の増加、2026年の1株当たり利益見通しの上方修正を受けて上昇した。

By

-- テネット・ヘルスケア(THC)の株価は、同社が第1四半期の調整後利益と売上高の増加を発表したことを受け、木曜日に小幅上昇した。 同社は第1四半期の調整後1株当たり利益(EPS)が4.82ドルとなり、前年同期の4.36ドルから増加したと発表した。ファクトセットが調査したアナリストは4.17ドルを予想していた。 3月31日締めの四半期の純営業収益は53億7000万ドルで、前年同期の52億2000万ドルから増加した。 ファクトセットが調査したアナリストは53億9000万ドルを予想していた。 2026年の調整後希薄化後1株当たり利益は、従来予想の16.19ドル~18.47ドルに対し、16.38ドル~18.68ドルと予想している。アナリストは17.22ドルを予想している。 通期の売上高見通しは215億ドル~223億ドルで据え置かれた。アナリストは220億1000万ドルを予想している。

Price: $180.51, Change: $+0.31, Percent Change: +0.17%

Related Articles

Research

Research Alert: CFRA Reiterates Strong Buy Opinion On Shares Of Lithia Motors Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month target by $25 to $375, based on a 2027 P/E of 9.0x, a modest discount to LAD's 10-year forward P/E of 10.3x. We reduce our adjusted EPS estimates to $35.30 from $39.25 for '26 and to $41.80 from $43.20 for '27. Following LAD's Q1 earnings beat, we are lowering our estimates and price target but reiterating our Strong Buy on the shares. LAD remains our top pick in auto retail, as the company continues to outperform in a more challenging environment for dealerships. LAD's same-store-sales growth is outperforming peers by a wide margin and its combination of aggressive share repurchases and accretive acquisitions is helping support its bottom line. Impressively, LAD bought back ~4% of total outstanding shares in Q1 after retiring 11% of its share count in 2025. We find LAD's current risk/reward compelling with significant upside potential in a more favorable demand environment, continuing to view the long-term growth story as intact and noting management's history of solid execution.

$LAD
Research

Kinross Gold Maintained at Buy at Stifel Canada Following Q1 Results; Price Target Kept atC$65.00

Stifel Canada on Thursday maintained its buy rating on the shares of Kinross Gold (K.TO, KGC) and its C$65.00 price target following the company's first-quarter results."Kinross reported Q1/26 adjusted EPS of $0.71 vs. our $0.69 (consensus: $0.72) on attributable GEO production of 492.6Koz vs. our 489.8Koz (consensus: 481.8Koz) at attributable cost of sales of $1,380/GEO and AISC of $1,732/GEO which were in-line and within the FY26 guidance ranges ($1,360 +/- 5% and $1,730 +/- 5%, respectively). Adjusted Q1/26 EPS absorbed a $91Mln withholding-tax charge, of which $65Mln relates to taxes payable in future quarters tied to repatriation of Mauritania cash flows. Record Q1/26 attributable FCF of $837.5Mln implies FCF/GEO ex-WC of $2,656/GEO (+$1,034/GEO or +63.8% QoQ vs. +$722/oz or +17.4% in gold price). Kinross repurchased $250.1Mln in shares in Q1/26 (plus $50Mln in April) and reaffirmed its 40%-of-FCF return-of-capital target. We estimate approx. $1.3Bln for share buybacks in 2026 (vs. $0.6Bln in 2025) or 3.4% of shares outstanding (vs. 2.5% in 2025). Q1/26 total liquidity stood at $3.9Bln, including $2.2Bln of cash (+$443Mln QoQ)," analyst Ralph Profiti wrote.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $40.93, Change: $+0.07, Percent Change: +0.17%

$K.TO$KGC
Australia

Stifel Nicolaus Raises ONEOK Price Target to $99 From $91

ONEOK (OKE) has an average rating of overweight and mean price target of $94.65, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $91.91, Change: $+2.59, Percent Change: +2.90%

$OKE